Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日Flu Hospitalization Rate Week 18, 2026?
Flu Hospitalization Rate Week 18, 2026?
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$17,846 Vol.
$17,846 Vol.
2026/05/15
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100.0%
<80 <1%
80–85 <1%
90–95 <1%
$17,846 Vol.
$17,846 Vol.
2026/05/15
<80
$1,606 Vol.
No
80–85
$1,729 Vol.
No
85–90
$8,496 Vol.
Yes
90–95
$3,413 Vol.
No
95–100
$1,787 Vol.
No
100+
$815 Vol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
マーケット開始日： May 8, 2026, 12:14 PM ET
音量
$17,846終了日
2026/05/15マーケット開始日
May 8, 2026, 12:14 PM ETResolver
0x69c47De9D...提案された結果: Yes
異議申し立てなし
最終結果: Yes
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
音量
$17,846終了日
2026/05/15マーケット開始日
May 8, 2026, 12:14 PM ETResolver
0x69c47De9D...提案された結果: Yes
異議申し立てなし
最終結果: Yes
Traders' near-unanimous consensus on the 85–90 per 100,000 range for cumulative influenza hospitalization reflects the latest CDC FluSurv-NET data through week 17 (ending May 2, 2026), reporting a rate of 86.0 per 100,000—the third highest since 2010–2011—with minimal weekly additions of just 0.2 per 100,000 amid low seasonal activity dominated by influenza A(H3N2). Declining trends since week 14's 84.5 rate, confirmed by FluSight nowcasts predicting few new admissions for week 18 (May 3–9), solidify this positioning, as further accruals are unlikely to exceed 90. Realistic challenges include upward revisions from delayed reporting or undercounted cases, though historical patterns suggest stability; the official FluView week 18 report, due soon, will confirm resolution.
Polymarketデータを参照したAI生成の実験的な要約。これは取引アドバイスではなく、このマーケットの解決方法には一切関係ありません。 · 更新日
外部リンクに注意してください。
外部リンクに注意してください。
よくある質問